New Agents and Evolving Strategies in Prostate Cancer: Focus on Castration-Sensitive Disease

Learn how experts select and carefully consider the toxicity profiles of established and newly emerging androgen-deprivation therapies toward the optimal management of patients with castration-sensitive prostate cancer. Download slides from the live symposium and read an expert-authored commentary on androgen-deprivation therapies for castration-sensitive prostate cancer.

Share

Program Content

No activities added yet

Activities

CSPC: Overview of Management
Overview of Recurrent and Metastatic Castration-Sensitive Prostate Cancer Management
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

CSPC: Comparison of ADTs
Comparison of Androgen-Deprivation Therapies for CSPC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

CSPC: Evolving Treatments
New Agents and Evolving Strategies for CSPC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

Activities

ADT Strategies for CSPC
New Agents and Evolving Strategies in Castration-Sensitive Prostate Cancer (CSPC)
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2022

Expires: March 29, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Myovant Sciences Inc

Pfizer, Inc.